Crossmark

Roux-en-Y Gastric Bypass Compared to Glucagon-Like Peptide-1 Receptor Agonists is Associated with Lower Out-of-Pocket Costs in Insured Patients with Type 2 Diabetes and Obesity: A Matched Analysis Over Two Years

Crossref DOI link: https://doi.org/10.1007/s11695-025-08467-3

Published Online: 2026-01-03

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Thiyagarajan, Sibi

Wall-Wieler, Elizabeth

Liu, Yuki

Zheng, Feibi

Edwards, Michael
License Information

Text and Data Mining valid from 2026-01-03

Version of Record valid from 2026-01-03
More Information

Article History

Received: 15 September 2025

Revised: 7 December 2025

Accepted: 21 December 2025

First Online: 3 January 2026

Declarations

:

: Intuitive Surgical Inc. funded access to the Merative™ MarketScan Research Databases used for this study. Three co-authors are employed by Intuitive Surgical, Inc. (EW, YL, FZ) and were involved in the design, analysis, or preparation of this manuscript. Author MAE is a recipient of an Intuitive Foundation Research Grant Award for another research project.

Document is current

Any future updates will be listed below